GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » YoY EBITDA Growth

Ontrak (Ontrak) YoY EBITDA Growth : 94.13% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Ontrak YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ontrak's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 94.13%.

Ontrak's EBITDA per Share for the three months ended in Dec. 2023 was $-0.09.

Ontrak YoY EBITDA Growth Historical Data

The historical data trend for Ontrak's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ontrak YoY EBITDA Growth Chart

Ontrak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.78 37.43 -61.30 -36.03 88.18

Ontrak Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.42 64.38 83.57 83.28 94.13

Ontrak YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ontrak's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.292--10.931)/ | -10.931 |
=88.18 %

Ontrak's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.094--1.6)/ | -1.6 |
=94.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ontrak YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ontrak's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ontrak (Ontrak) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » YoY EBITDA Growth
Comparable Companies
HLCO ICCT NHIQ LIFW CMAX HCTI CCLD UPHL PBSV OHCS GEHC VEEV SOLVw TSE:2413 ASX:PME HQY RCM DOCS TXG EVH
Traded in Other Exchanges
OTRKP.PFD:USA HY10:Germany HY10:Germany
Address
2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052
Website
https://www.ontrakhealth.com
Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.
Executives
Judith Feld officer: Chief Medical Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina director 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill officer: Chief Information Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino officer: Chief Medical Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne officer: Chief Customer Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park officer: Chief Accounting Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew officer: Chief Executive Officer ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer director, 10 percent owner, officer: CEO 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton officer: General Counsel and Secretary 1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak director 2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros officer: Chief Operating Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne officer: Chief Financial Officer 1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith 10 percent owner 888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo director 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404